NCT00028938View on ClinicalTrials.gov

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 1, 2002

Primary Completion Date

November 10, 2002

Study Completion Date

November 10, 2002

Conditions
Lung Cancer
Interventions
BIOLOGICAL

epoetin alfa

DRUG

carboplatin

DRUG

paclitaxel

RADIATION

radiation therapy

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00028938 - Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter